Fragasso Financial Advisors Inc Sells 128 Shares of The Procter & Gamble Company (NYSE:PG)

Fragasso Financial Advisors Inc decreased its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 1.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,440 shares of the company’s stock after selling 128 shares during the period. Fragasso Financial Advisors Inc’s holdings in Procter & Gamble were worth $1,750,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of PG. Acorn Creek Capital LLC raised its position in shares of Procter & Gamble by 2.8% in the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after acquiring an additional 59 shares in the last quarter. Patrick M Sweeney & Associates Inc. raised its position in shares of Procter & Gamble by 1.1% in the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after acquiring an additional 59 shares in the last quarter. Traveka Wealth LLC raised its position in shares of Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after acquiring an additional 60 shares in the last quarter. Allen Mooney & Barnes Investment Advisors LLC raised its position in shares of Procter & Gamble by 0.7% in the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock worth $1,507,000 after acquiring an additional 61 shares in the last quarter. Finally, Valued Wealth Advisors LLC raised its position in shares of Procter & Gamble by 11.2% in the 3rd quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock worth $105,000 after acquiring an additional 61 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on PG. Evercore ISI increased their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Morgan Stanley upped their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. JPMorgan Chase & Co. upped their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Piper Sandler began coverage on Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target on the stock. Finally, Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research note on Monday, September 30th. Eight equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $179.75.

Procter & Gamble Stock Performance

Procter & Gamble stock traded up $0.78 during trading on Monday, reaching $159.34. The company had a trading volume of 3,292,309 shares, compared to its average volume of 6,346,956. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43. The firm’s 50-day simple moving average is $169.64 and its 200 day simple moving average is $169.61. The firm has a market capitalization of $375.25 billion, a price-to-earnings ratio of 27.47, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. Procter & Gamble’s revenue for the quarter was down .6% compared to the same quarter last year. During the same period last year, the firm earned $1.83 EPS. Sell-side analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the transaction, the chief executive officer now owns 39,977 shares in the company, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the transaction, the chief executive officer now owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 75,439 shares of company stock valued at $13,317,460 over the last ninety days. 0.18% of the stock is currently owned by company insiders.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.